Not all individuals with CLL need therapy. In spite of all modern innovations, the iwCLL still suggests watchful observation for individuals with asymptomatic condition.86 This advice is based on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Ini memungkinkan https://annelig196ygn3.ttblogs.com/profile